A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian Cancer
Clinical trial NCT04718376 · TERMINATED
Trial details
- NCT number
- NCT04718376
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-12
- Primary completion
- 2023-05-22
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.